CreativeOne Wealth’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.05M Buy
38,953
+9,532
+32% +$650K 0.07% 285
2026
Q1
$1.9M Buy
29,421
+16,720
+132% +$1.18M 0.04% 366
2025
Q4
$855K Sell
12,701
-1,096
-8% -$73.7K 0.02% 616
2025
Q3
$1.01M Sell
13,797
-2,762
-17% -$183K 0.02% 548
2025
Q2
$861K Sell
16,559
-1,097
-6% -$62.4K 0.02% 583
2025
Q1
$1.13M Sell
17,656
-727
-4% -$42.2K 0.03% 443
2024
Q4
$879K Buy
18,383
+294
+2% +$15.1K 0.03% 510
2024
Q3
$1.04M Buy
+18,089
New +$1.04M 0.04% 427
2023
Q1
Sell
-4,744
Closed -$270K 808
2022
Q4
$270K Buy
+4,744
New +$243K 0.01% 604

Other funds holding HALO

CreativeOne Wealth's HALO Position: Q2 2026 in Review

CreativeOne Wealth increased its Halozyme (HALO) stake by 32% in Q2 2026, buying an estimated $650K and bringing the position to 38,953 shares worth $3.05M. The position accounts for 0.07% of the portfolio, ranked #285.

CreativeOne Wealth first reported a position in HALO in Q4 2022 and has held it in 9 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • CreativeOne Wealth held 38,953 shares of Halozyme worth $3.05M as of Q2 2026.
  • CreativeOne Wealth bought 9,532 Halozyme shares in Q2 2026, an estimated $650K.
  • Halozyme made up 0.07% of CreativeOne Wealth's portfolio in Q2 2026, its #285 holding.
  • CreativeOne Wealth first reported a position in Halozyme in Q4 2022 and has held it in 9 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.